Bringing the human touch to oncology
Based on our success with Quadramet©, Cytogen asked us to energize ProstaScint©, their under-performing prostate cancer diagnostic test. Physicians didn’t understand the clinical benefit of the test, and were also concerned with the perceived difficulties in interpreting the results.